Vascular risk factors and cognitive decline among elderly male twins

Neurology

Volumn 67, Issue 9, 2006, Pages 1586-1591

  Xiong, Glen L ^a   Plassman, Brenda L ^a   Helms, Michael J ^a   Steffens, David C ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; BODY MASS; CARDIOVASCULAR RISK; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; DEMENTIA; DIABETES MELLITUS; DISEASE ASSOCIATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL RESEARCH; PRIORITY JOURNAL; TELEPHONE; TWINS;

AGE FACTORS; AGED; AGED, 80 AND OVER; AGING; BLOOD VESSELS; BRAIN; CARDIOVASCULAR DISEASES; COGNITION DISORDERS; COHORT STUDIES; COMORBIDITY; DIABETES COMPLICATIONS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; INTERVIEWS; MALE; METABOLIC DISEASES; METABOLIC SYNDROME X; MIDDLE AGED; OBESITY; REGISTRIES; RISK FACTORS; SEX FACTORS; UNITED STATES;

EID: 33751006725     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.wnl.0000242730.44003.1d     Document Type: Article

References (44)

1. Feigin V, Ratnasabapathy Y, Anderson C. Does blood pressure lowering treatment prevent dementia or cognitive decline in patients with cardiovascular and cerebrovascular disease? J Neurol Sci 2005;230:151-155.
2. Anstey K, Christensen H. Education, activity, health, blood pressure and apolipoprotein E as predictors of cognitive change in old age: a review. Gerontology 2000;46:163-177.
3. Stewart R, Liolitsa D. Type 2 diabetes mellitus, cognitive impairment and dementia. Diabet Med 1999;16:93-112.
4. Awad N, Gagnon M, Messier C. The relationship between impaired glucose tolerance, type 2 diabetes, and cognitive function. J Clin Exp Neuropsychol 2004;26:1044-1080.
5. Robertson-Tchabo EA, Arenberg D, Tobin JD, Plotz JB. A longitudinal study of cognitive performance in noninsulin dependent (type II) diabetic men. Exp Gerontol 1986;21:459-467.
6. Elias MF, Schultz NR, Robbins NR, Elias PK. A longitudinal study of neuropsychological performance by hypertensives and normotensives: a third measurement point. J Gerontol Psychol Sci 1989;45:25-28.
7. Aleman A, Muller J, de Haan EHF, van der Schouw YT. Vascular risk factors and cognitive function in a sample of independently living men. Neurobiol Aging 2005;26:485-490.
8. Morris MC, Scherr PA, Hebert LE, et al. Association between blood pressure and cognitive function in a biracial community population of older persons. Neuroepidemiology 2002;21:123-130.
9. Elias PK, Elias MF, D'Agostino RB, et al. NIDDM and blood pressure as risk factor for poor cognitive performance. The Framingham Study. Diabetes Care 1997;20:1388-1395.
10. Hassing LB, Hofer SM, Nilsson SE, et al. Comorbid type 2 diabetes mellitus and hypertension exacerbates cognitive decline: evidence from a longitudinal study. Age Ageing 2004;33:355-361.
11. Jablon S, Neel JV, Gershowitz H, Atkinson GF. The NAS-NRC twin panel: methods of construction of the panel, zygosity diagnosis and proposed use. Am J Hum Genet 1967;19:133-161.
12. Hrubec Z, Neel JV. The National Academy of Sciences-National Research Council Twin Registry: ten years of operation. Prog Clin Biol Res 1978;24:153-172.
13. Reed T, Plassman BL, Tanner CM, Dick DM, Rinehart SA, Nichols WC. Verification of self-report of zygosity determined via DNA testing in a subset of the NAS-NRC Twin Registry 40 years later. Twin Res Hum Genet 2005;8:362-367.
14. Brandt J, Spencer M, Folstein M. The Telephone Interview for Cognitive Status. Neuropsychiatry Neuropsychol Behav Neurol 1988;1:111-117.
15. Welsh KA, Breitner JCS, Magruder-Habib KM. Detection of dementia in the elderly using telephone screening of cognitive status. Neuropsychiatry Neuropsychol Behav Neurol 1993;6:103-110.
16. Plassman BL, Newman TT, Welsh KA, Helms M, Breitner JCS. Properties of the Telephone Interview for Cognitive Status. Application in epidemiological and longitudinal studies. Neuropsychiatry Neuropsychol Behav Neurol 1994;7:235-241.
17. Breitner JCS, Welsh KA, Gau BA, et al. Alzheimer's disease in the National Academy of Sciences-National Research Council Registry of aging twin veterans. III. Detection of cases, longitudinal results, and observations on twin concordance. Arch Neurol 1995;52:763-771.
18. Gallo JJ, Breitner JCS. Alzheimer's disease in the N.A.S.-N.R.C. Registry of aging twin veterans. IV. Performance characteristics of a two-stage telephone screening procedure for Alzheimer's dementia. Psychol Med 1995;25:1211-1219.
19. Khachaturian AS, Gallo JJ, Breitner JCS. Performance characteristics of a two-stage dementia screen in a population sample. J Clin Epidemiol 2000;53:531-540.
20. Plassman BL, Khachaturian AS, Townsend JJ, et al. Comparison of clinical and neuropathological diagnoses of AD in three epidemiological samples. Alzheimer Dementia 2006;2:2-11.
21. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
22. Carmelli D, Swan GE, Reed T, et al. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology 1998;50:1580-1585.
23. Fontbonne A, Berr C, Ducimetiere P, Alperovitch A. Changes in cognitive abilities over a 4-year period are unfavorably affected in elderly diabetic subjects. Diabetes Care 2001;24:366-370.
24. Ryan CM, Geckle M. Why is learning and memory dysfunction in type 2 diabetes limited to older adults? Diabetes Metab Res Rev 2000;16:308-315.
25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 2001;285:2486-2497.
26. Kalmijn S, Foley D, White L, et al. Metabolic cardiovascular syndrome and risk of dementia in Japanese-American elderly men. The Honolulu-Asia Aging Study. Arterioscler Thromb Vasc Biol 2000;20:2255-2260.
27. Yaffe K, Kanaya A, Lindquist K, et al. The metabolic syndrome, inflammation, and risk of cognitive decline. JAMA 2004;292:2237-2242.
28. Kahn R, Buse J, Ferrannini E, Stern M. The metabolic syndrome: time for critical appraisal. Diabetes Care 2005;28:2289-2304.
29. Kumari M, Brunner E, Fuhrer R. Minireview: mechanisms by which the metabolic syndrome and diabetes impair memory. J Gerontol 2000;55A:B228-232.
30. Biessels GJ, Kappelle LJ, Utrecht Diabetic Encephalopathy Study Group. Increased risk of Alzheimer's disease in type II diabetes: insulin resistance of the brain or insulin-induced amyloid pathology. Biochem Soc Trans 2005;33:1041-1044.
31. Farris W, Mansourian S, Chang Y, et al. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Proc Natl Acad Sci USA 2003;100:4162-4167.
32. Dey J, Misra A, Desai NG, Mahapatra AK, Padma MV. Cognitive function in younger type II diabetes. Diabetes Care 1997;20:32-35.
33. Vanhanen M, Koivisto K, Karjalainen L, et al. Risk for non-insulin-dependent diabetes in the normoglycaemic elderly is associated with impaired cognitive function. Neuroreport 1997;8:1527-1530.
34. Ott A, Stolk RP, van Harskamp F, Pols HAP, Hofman A, Breteler MMB. Diabetes mellitus and the risk of dementia. Neurology 1999;53:1937-1942.
35. Haan MN, Mungas DM, Gonzalez HM, Ortiz TA, Acharya A, Jagust WJ. Prevalence of dementia in older Latinos: the influence of type 2 diabetes mellitus, stroke and genetic factors. J Am Geriatr Soc 2003;51:169-177.
36. Peila R, Rodriguez BL, Launer LJ. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies. The Honolulu-Asia Aging Study. Diabetes 2002;51:1256-1262.
37. Luchsinger JA, Tang M-X, Stern Y, Shea S, Mayeaux R. Diabetes mellitus and risk of Alzheimer's disease and dementia with stroke in a multiethnic cohort. Am J Epidemiol 2001;154:635-641.
38. Klabunde CN, Reeve BB, Harlan LC, Davis WW, Potosky AL. Do patients consistently report comorbid conditions over time? Results from the prostate cancer outcomes study. Med Care 2005;43:391-400.
39. Okura Y, Urban LH, Mahoney DW, Jacobsen SJ, Rodeheffer RJ. Agreement between self-report questionnaires and medical record data was substantial for diabetes, hypertension, myocardial infarction and stroke but not for heart failure. J Clin Epidemiol 2004;57:1096-1103.
40. St Sauver JL, Hagen PT, Cha SS, et al. Agreement between patient reports of cardiovascular disease and patient medical records. Mayo Clin Proc 2005;80:203-210.
41. Kuo HK, Sorond F, Iloputaife I, Gagnon M, Milberg W, Lipsitz LA. Effect of blood pressure on cognitive function in elderly persons. J Gerontol A Biol Sci Med Sci 2004;59:1191-1194.
42. Lines CR, McCarroll KA, Lipton RB, Block GA. Telephone screening for amnestic mild cognitive impairment. Neurology 2003;60:261-266.
43. de Jager CA, Budge MM, Clarke R. Utility of TICS-M for the assessment of cognitive function in older adults. Int J Geriatr Psychiatry 2003;18:318-324.
44. Potter GG, Plassman BL, Helms MJ, Steffens DC, Welsh-Bohmer KA. Age effects of coronary artery bypass on cognitive status change among elderly male twins. Neurology 2004;63:2245-2249.